122 related articles for article (PubMed ID: 8203922)
21. Detection of K-ras and p53 mutations in bronchoscopically obtained malignant and non-malignant tissue from patients with non-small cell lung cancer.
Lang SM; Stratakis DF; Freudling A; Ebelt K; Oduncu F; Hautmann H; Huber RM
Eur J Med Res; 2000 Aug; 5(8):341-6. PubMed ID: 10958767
[TBL] [Abstract][Full Text] [Related]
22. [C-myc activation by translocation in human primary non-small cell lung cancer].
Lu Y; Cheng S; Guo S
Zhonghua Yi Xue Za Zhi; 1996 Apr; 76(4):275-7. PubMed ID: 8758273
[TBL] [Abstract][Full Text] [Related]
23. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
[TBL] [Abstract][Full Text] [Related]
24. [Flow cytometric analysis of the DNA content of sclerosing hemangioma of the lung].
Matsuki Y; Ihara N; Satoh Y; Kokai Y; Takanashi R
Rinsho Byori; 1993 Feb; 41(2):227-9. PubMed ID: 8395613
[TBL] [Abstract][Full Text] [Related]
25. Discerning malignancy in human adrenocortical neoplasms: utility of DNA flow cytometry and immunohistochemistry.
Suzuki T; Sasano H; Nisikawa T; Rhame J; Wilkinson DS; Nagura H
Mod Pathol; 1992 May; 5(3):224-31. PubMed ID: 1353877
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometric analysis of c-myc oncoprotein in non-small-cell lung carcinoma: comparison with immunohistochemical results.
De Santis L; Mangili F; Sassi I; Di Rocco M; Rossi C; Cantaboni A
Anal Cell Pathol; 1995 Apr; 8(3):247-57. PubMed ID: 7547497
[TBL] [Abstract][Full Text] [Related]
27. [Flow cytometric analysis of nuclear DNA content of lung cancer--correlation between nuclear DNA content and tumor doubling time].
Usuda K; Saito Y; Aikawa H; Sakurada A; Chen Y; Takahashi S; Kanma K; Sato M; Sagawa M; Fujimura S
Nihon Kyobu Geka Gakkai Zasshi; 1994 Apr; 42(4):486-91. PubMed ID: 8035066
[TBL] [Abstract][Full Text] [Related]
28. Quantitation of biological tumor markers (p53, c-myc, Ki-67 and DNA ploidy) by multiparameter flow cytometry in non-small-cell lung cancer.
Mørkve O; Halvorsen OJ; Stangeland L; Gulsvik A; Laerum OD
Int J Cancer; 1992 Dec; 52(6):851-5. PubMed ID: 1334053
[TBL] [Abstract][Full Text] [Related]
29. Expression of telomerase hTERT in human non-small cell lung cancer and its correlation with c-myc gene.
Geng Z; Zhang D; Liu Y
Chin Med J (Engl); 2003 Oct; 116(10):1467-70. PubMed ID: 14570602
[TBL] [Abstract][Full Text] [Related]
30. [Flow cytometric analysis of cellular DNA content of lung cancer with reference to survival].
Shiota T; Konishi T; Kosaba S; Mitsuoka A; Matsubara Y; Hatakenaka R; Funatsu T; Ikeda S; Matsumoto H; Ishigami F
Nihon Kyobu Geka Gakkai Zasshi; 1990 Dec; 38(12):2364-9. PubMed ID: 2290045
[TBL] [Abstract][Full Text] [Related]
31. DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma.
Roa I; Villaseca M; Araya JC; Roa J; de Aretxabala X; Fuentealba P; Melo A
Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):547-50. PubMed ID: 9232344
[TBL] [Abstract][Full Text] [Related]
32. [Contribution of flow cytometry in the prognostic evaluation of non-small-cell lung cancers. Review of the literature].
Jeanfaivre T; Chassevent A; Larra F; Tuchais E
Bull Cancer; 1994 Jul; 81(7):605-9. PubMed ID: 7742603
[TBL] [Abstract][Full Text] [Related]
33. The correlation between the expression of p53 protein and DNA ploidy in patients with gastric cancer that has invaded the serosa.
Wang Z; Ikeguchi M; Maeta M; Kaibara N
Anticancer Res; 1997; 17(5A):3701-5. PubMed ID: 9413227
[TBL] [Abstract][Full Text] [Related]
34. [Expressions of 8-OH-dG, k-ras, and p53 genes in pleural effusion cells and their clinical significances].
Fu XY; Bin XN; Tan M
Ai Zheng; 2005 Mar; 24(3):345-8. PubMed ID: 15757539
[TBL] [Abstract][Full Text] [Related]
35. [Prognostic value of flow cytometry in squamous cell bronchogenic cancer. A retrospective study of 61 cases].
Jeanfaivre T; Chassevent A; Geslin J; Larra F; Tuchais E
Bull Cancer; 1997 Jun; 84(6):597-602. PubMed ID: 9295862
[TBL] [Abstract][Full Text] [Related]
36. [The experimental study on telomerase activity and expression of p53 and c-myc genes in tongue cancer].
Fang Z; Li H; Wang C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Aug; 21(4):274-6. PubMed ID: 14513581
[TBL] [Abstract][Full Text] [Related]
37. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
38. Expression of c-erbB2, p53, Bcl-2, Bax, c-myc and Ki-67 in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast.
Selim AG; El-Ayat G; Wells CA
Virchows Arch; 2002 Nov; 441(5):449-55. PubMed ID: 12447674
[TBL] [Abstract][Full Text] [Related]
39. [DNA flow cytometry in the prognostication of certain malignant neoformations].
Nikolaeva TG; Dobrynin IaV; Akhundov AA; Prorokov VV; Davydov MI
Vopr Onkol; 2001; 47(6):684-9. PubMed ID: 11826489
[TBL] [Abstract][Full Text] [Related]
40. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
